BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17447201)

  • 1. Natural compounds as inhibitors of human neutrophil elastase.
    Siedle B; Hrenn A; Merfort I
    Planta Med; 2007 May; 73(5):401-20. PubMed ID: 17447201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Phenolics as Inhibitors of the Human Neutrophil Elastase (HNE) Release: An Overview of Natural Anti-inflammatory Discoveries during Recent Years.
    Saleem M; Nazir M; Hussain H; Tousif MI; Elsebai MF; Riaz N; Akhtar N
    Antiinflamm Antiallergy Agents Med Chem; 2018; 17(2):70-94. PubMed ID: 30198444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical constituents from the leaves of Ilex paraguariensis inhibit human neutrophil elastase.
    Xu GH; Kim YH; Choo SJ; Ryoo IJ; Yoo JK; Ahn JS; Yoo ID
    Arch Pharm Res; 2009 Sep; 32(9):1215-20. PubMed ID: 19784576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant phenolics inhibit neutrophil elastase.
    Hrenn A; Steinbrecher T; Labahn A; Schwager J; Schempp CM; Merfort I
    Planta Med; 2006 Oct; 72(12):1127-31. PubMed ID: 17024589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphonic pseudopeptides as human neutrophil elastase inhibitors--a combinatorial approach.
    Sieńczyk M; Podgórski D; Błażejewska A; Kulbacka J; Saczko J; Oleksyszyn J
    Bioorg Med Chem; 2011 Feb; 19(3):1277-84. PubMed ID: 21216608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly potent irreversible inhibitors of neutrophil elastase generated by selection from a randomized DNA-valine phosphonate library.
    Charlton J; Kirschenheuter GP; Smith D
    Biochemistry; 1997 Mar; 36(10):3018-26. PubMed ID: 9062133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydoroxyhibiscone A, a novel human neutrophil elastase inhibitor from Hibiscus syriacus.
    Ryoo IJ; Yun BS; Lee IK; Kim YH; Lee IS; Ahn JS; Bae K; Yoo ID
    J Microbiol Biotechnol; 2010 Aug; 20(8):1189-91. PubMed ID: 20798580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailoring elastase inhibition with synthetic peptides.
    Vasconcelos A; Azoia NG; Carvalho AC; Gomes AC; Güebitz G; Cavaco-Paulo A
    Eur J Pharmacol; 2011 Sep; 666(1-3):53-60. PubMed ID: 21658384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory activity of neutrophil elastase inhibitors.
    Tremblay GM; Janelle MF; Bourbonnais Y
    Curr Opin Investig Drugs; 2003 May; 4(5):556-65. PubMed ID: 12833649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil elastase inhibitors: recent advances in the development of mechanism-based and nonelectrophilic inhibitors.
    Sjö P
    Future Med Chem; 2012 Apr; 4(5):651-60. PubMed ID: 22458683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
    Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
    Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and alpha 1-proteinase inhibitor.
    Belorgey D; Bieth JG
    Biochemistry; 1998 Nov; 37(46):16416-22. PubMed ID: 9819234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
    Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
    Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors.
    Dau T; Sarker RS; Yildirim AO; Eickelberg O; Jenne DE
    Nat Commun; 2015 Apr; 6():6722. PubMed ID: 25857284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinnoline derivatives as human neutrophil elastase inhibitors.
    Giovannoni MP; Schepetkin IA; Crocetti L; Ciciani G; Cilibrizzi A; Guerrini G; Khlebnikov AI; Quinn MT; Vergelli C
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):628-39. PubMed ID: 26194018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation.
    Matsuzaki K; Hiramatsu Y; Homma S; Sato S; Shigeta O; Sakakibara Y
    Ann Thorac Surg; 2005 Aug; 80(2):611-7. PubMed ID: 16039215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratracheally-instilled antileukoprotease and alpha 1-proteinase inhibitor: effect on human neutrophil elastase-induced experimental emphysema and pulmonary localization.
    Rudolphus A; Kramps JA; Mauve I; Dijkman JH
    Histochem J; 1994 Oct; 26(10):817-24. PubMed ID: 7883591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a highly water-soluble peptide-based human neutrophil elastase inhibitor; AE-3763 for treatment of acute organ injury.
    Inoue Y; Omodani T; Shiratake R; Okazaki H; Kuromiya A; Kubo T; Sato F
    Bioorg Med Chem; 2009 Nov; 17(21):7477-86. PubMed ID: 19811924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-peptidic inhibitors of human neutrophil elastase: the design and synthesis of sulfonanilide-containing inhibitors.
    Imaki K; Okada T; Nakayama Y; Nagao Y; Kobayashi K; Sakai Y; Mohri T; Amino T; Nakai H; Kawamura M
    Bioorg Med Chem; 1996 Dec; 4(12):2115-34. PubMed ID: 9022976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evaluation of selected, orally active, peptidyl inhibitors of human neutrophil elastase.
    Janusz MJ; Durham SL; Hare CM; Geary JL; Mandagere AK; Poole JC; Thompson TN; Xu D; Anagelastro MR; Burkhart JP
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1233-8. PubMed ID: 8531086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.